Ask most search engines whether a medical college in India can be a for-profit company, and you'll get a confident non-profit-only answer, usually pointing to the National Medical Commission's rules. That answer has been true, false, true again, and is currently disputed between two different arms of the Indian state — all within about nine years.

The company is Vedanta. In 2017, the mining and resources conglomerate established the Vedantaa Institute of Medical Sciences in Palghar, Maharashtra, through Vedantaa Institutes of Academic Excellence Private Limited — reported as the first medical college in India promoted by a private limited company. The institute reportedly argued that, as a genuinely for-profit entity, its fee structure fell outside the state fee-regulatory authority's jurisdiction — a real regulatory flashpoint, not a footnote. It could exist at all because of a specific policy window: in January 2017, the Medical Council of India, the regulator at the time, amended its rules to let any company — not just non-profit ones — establish a medical college.

Three Reversals in Nine Years

The regulatory position has moved back and forth since Vedanta's college opened, and it hasn't settled yet:

The part that makes this genuinely unresolved, not just historical: on 28 January 2026 — the same month as the NMC's reversal — a Division Bench of the Bombay High Court upheld Rule 6(g) of the 2023 Regulations in a specific case, ruling that medical colleges "should not be built for profit-making motives and must remain aligned with public interest." The petitioners had challenged the rule as exceeding the NMC's powers under the NMC Act and violating Articles 14 (equality) and 19(1)(g) (freedom to carry on business) of the Constitution; the court rejected that challenge and upheld the restriction. That means the regulator's current policy and a live court ruling on the same underlying rule are pointing in opposite directions, in the same month, right now. This is based on consistent, independent reporting rather than the judgment itself — worth confirming directly against the full order before relying on the specifics in any transaction — but the core tension it describes, between an evolving regulatory policy and a court decision going the other way, is well-corroborated.

Why This Matters Beyond Medical Education Specifically

We've written before about a parallel myth in K-12 schools — where search engines confidently state a blanket non-profit rule that turns out to depend on which state and which board is involved. The medical college story is the same underlying pattern with a sharper edge: not just an overlooked exception, but a rule that has genuinely changed direction multiple times, with the regulator and the judiciary currently not fully aligned. Both stories point to the same lesson for anyone evaluating an Indian education-sector transaction: the "non-profit only" answer that shows up in a quick search is frequently a snapshot of one moment in an evolving position, not a stable, permanent rule. We've since found the mirror image of this pattern in skilling centres and coaching centres, where the non-profit assumption doesn't apply at all — by design, not by exception.

For education and healthcare deal-making specifically, this has an immediate practical consequence: any transaction premised on a medical college's current for-profit eligibility needs that eligibility verified as of the actual transaction date, not assumed from a policy announcement — given how recently, and how actively, this exact rule has moved.

Evaluating a medical or health-education institution's ownership structure?

MAS Advisory tracks this exact regulatory question directly — talk to us before assuming today's rule will still apply at signing.

Start a conversation →

Based on reporting from Medical Dialogues, Careers360, and industry summaries of the National Medical Commission's January 2026 policy announcement and its 2023 and 2017/erstwhile MCI regulatory history, including reported details of the Vedantaa Institute of Medical Sciences' establishment and its fee-jurisdiction position. The 28 January 2026 Bombay High Court ruling upholding Rule 6(g) is based on consistent reporting across independent sources rather than the judgment itself — confirm directly against the full order before relying on specific details in a transaction. General guidance only; this is an actively evolving regulatory area and the current position should always be verified directly before any transaction.